Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma

doi:10.3748/wjg.14.1274

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2963)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

295

HTML

2442

Figures (1-5)

226

Sum=2963

Feb 28, 2008 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Feb 28, 2008; 14(8): 1274-1279
Published online Feb 28, 2008. doi: 10.3748/wjg.14.1274

Full Size Figure Download Figure

Figure 4 CNHK300, ONYX-015 and wtAd5 proliferation multiples in hepatocellular cancer cells HepGII, Hep3B and normal fibroblast cells BJ after 48 h virus infection. CNHK300 replicated by 40 625 and 65 326 folds on tumor cell HepGII and Hep3B, similar to those of wtAd5. The CNHK300 replication (180-folds) was attenuated significantly as compared with wtAd5 (4000-folds) in BJ normal cell lines.

Citation: Li YM, Song ST, Jiang ZF, Zhang Q, Su CQ, Liao GQ, Qu YM, Xie GQ, Li MY, Ge FJ, Qian QJ. Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma. World J Gastroenterol 2008; 14(8): 1274-1279
URL: https://www.wjgnet.com/1007-9327/full/v14/i8/1274.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1274